Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Cat study provides insight into dementia progress
The latest findings also reinforce the benefit of cat owners recognising signs of disease.
The study found parallels in the development of cognitive disease in both cats and humans. 

The University of Edinburgh Royal (Dick) School of Veterinary Studies, alongside the University of California, has found that key proteins linked to cognitive disease are found in similar ways in both cats and humans.
 
This new research demonstrates that the development of feline cognitive dysfunction syndrome (CDS) functions similarly to dementia in several ways. 

It is hoped that these findings will support fast diagnosis and treatment of cognitive disease in cats and humans, as they assist in understanding the indicators of the disease. 

In the study, researchers aimed to understand how beta-amyloid and tau, two key proteins, develop in cats of all ages, and how they relate to the development of CDS. 

The research ultimately found that the accumulation of tau proteins, and the region in the brain in which this occurs, are key indicators of the progress of dementia in cats, and that the clinical signs developed in feline CDS are similar to that of human Alzheimers disease. 

Published in Frontiers in Aging, the study is available to read here

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.